Basket

0544873 - ÚMG 2022 RIV GR eng J - Journal Article
Hrdinová, T. - Toman, O. - Dresler, J. - Klimentová, J. - Šalovská, Barbora - Pajer, P. - Bartoš, O. - Polívková, V. - Linhartová, J. - Poláková, K. - Kabickova, H. - Brodská, B. - Krijt, M. - Zivny, J. - Vyoral, D. - Petrák, J.
Exosomes released by imatinib-resistant K562 cells contain specific membrane markers, IFITM3, CD146 and CD36 and increase the survival of imatinib-sensitive cells in the presence of imatinib.
International Journal of Oncology. Roč. 58, č. 2 (2021), s. 238-250. ISSN 1019-6439. E-ISSN 1791-2423
R&D Projects: GA MŠMT(CZ) ED1.1.00/02.0109
Institutional support: RVO:68378050
Keywords : chronic myeloid leukemia * imatinib mesylate * drug resistance * proteomics * exosome * tyrosine kinase inhibitor * surface marker
OECD category: Oncology
Impact factor: 5.884, year: 2021
Method of publishing: Limited access
https://www.spandidos-publications.com/10.3892/ijo.2020.5163
Permanent Link: http://hdl.handle.net/11104/0321671